Merck MRK
NYSE MRK
$145.93 +0.74 (+0.51%)
As of: Oct 16, 2026 · 3:59 PM EDT

Merck (MRK) Income from Discontinued Operations (2020 - 2021)

Updated

Merck's Income from Discontinued Operations was -$62 million in Q4 2021, compared with $523 million a year earlier.

Analysis

Merck (MRK) Income from Discontinued Operations (2020 - 2021) Analysis & Trends

For FY2021, Income from Discontinued Operations at Merck came in at $707 million, down 72.4% from FY2020.

  • In earlier years, Income from Discontinued Operations was $2.56 billion in FY2020 (-38.6%) and $4.17 billion in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn -
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn -
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn -
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn -
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn -
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn -
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 8.00 Mn
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -62.00 Mn
Jun 30, 2021 332.00 Mn
Mar 31, 2021 437.00 Mn
Dec 31, 2020 523.00 Mn
Sep 30, 2020 619.00 Mn
Jun 30, 2020 665.00 Mn
API Access

Merck Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=MRK&period=max&api_key=YOUR_API_KEY